Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering
James R. Tribble, Flora Hui, Heberto Quintero, et al.
Molecular Aspects of Medicine (2023) Vol. 92, pp. 101193-101193
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium
Jonathan R. Soucy, Erika A. Aguzzi, Julie Cho, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 31
Neurovascular dysfunction in glaucoma
Luis Alarcón-Martínez, Yukihiro Shiga, Deborah Villafranca‐Baughman, et al.
Progress in Retinal and Eye Research (2023) Vol. 97, pp. 101217-101217
Open Access | Times Cited: 27
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
Ghazi O. Bou Ghanem, Lauren K. Wareham, David J. Calkins
Progress in Retinal and Eye Research (2024) Vol. 100, pp. 101261-101261
Open Access | Times Cited: 13
Emerging trends in long-acting sustained drug delivery for glaucoma management
Yin So, Deepakkumar Mishra, Sandip Gite, et al.
Drug Delivery and Translational Research (2025)
Open Access | Times Cited: 1
Stress, Allostatic Load, and Neuroinflammation: Implications for Racial and Socioeconomic Health Disparities in Glaucoma
Colleen E. McDermott, Rebecca Salowe, Isabel Di Rosa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1653-1653
Open Access | Times Cited: 7
Epigenetics in Glaucoma
Fabiana D’Esposito, Caterina Gagliano, Philip Bloom, et al.
Medicina (2024) Vol. 60, Iss. 6, pp. 905-905
Open Access | Times Cited: 7
Massively parallel sequencing of mitochondrial genome in primary open angle glaucoma identifies somatically acquired mitochondrial mutations in ocular tissue
Neeru A. Vallabh, Brian Lane, David Simpson, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
A Method for Ocular Disease Diagnosis through Visual Prediction Explainability
Antonella Santone, Mario Cesarelli, Emanuella Colasuonno, et al.
Electronics (2024) Vol. 13, Iss. 14, pp. 2706-2706
Open Access | Times Cited: 6
Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiology
Devaraj Basavarajappa, Caridad Galindo‐Romero, Vivek Gupta, et al.
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101216-101216
Open Access | Times Cited: 13
Assessing the efficacy of 2D and 3D CNN algorithms in OCT-based glaucoma detection
Rafiul K. Rasel, Fengze Wu, Marion Chiariglione, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Biomedical applications of prokaryotic carbonic anhydrases: an update
Clemente Capasso, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 5, pp. 351-363
Closed Access | Times Cited: 5
Ocular Inflammation and Oxidative Stress as a Result of Chronic Intermittent Hypoxia: A Rat Model of Sleep Apnea
N. T. Donkor, Jennifer J. Gardner, Jessica L. Bradshaw, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 878-878
Open Access | Times Cited: 4
NMNAT2 is a druggable target to drive neuronal NAD production
James R. Tribble, Melissa Jöe, Carmine Varricchio, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Insulin restores retinal ganglion cell functional connectivity and promotes visual recovery in glaucoma
Sana El Hajji, Yukihiro Shiga, Nicolás Belforte, et al.
Science Advances (2024) Vol. 10, Iss. 32
Open Access | Times Cited: 4
IOP-induced blood-retinal barrier compromise contributes to RGC death in glaucoma
Chi Zhang, Marina Simón, Haeyn Lim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
The role of neurotrophic factors in retinal ganglion cell resiliency
Anina Abraham, Michael Telias
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Retina-Targeted 17β-Estradiol by the DHED Prodrug Rescues Visual Function and Actuates Neuroprotective Protein Networks After Optic Nerve Crush in a Rat Model of Surgical Menopause
Katalin Prókai‐Tátrai, Khadiza Zaman, Ammar Kapic, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1846-1846
Open Access
The global burden of blindness and vision loss caused by type 2 diabetes mellitus from 1990 to 2021 and projections to 2050: findings from global burden of disease 2021
Jiamin Cao, Xiajing Liu, Yongquan Zhang, et al.
Critical Public Health (2025) Vol. 35, Iss. 1
Open Access
Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment
Hamoudi Ghassan Awde Alfonso, Luis Ignacio Tártara, Alejandro J. Paredes, et al.
International Journal of Pharmaceutics (2025), pp. 125440-125440
Closed Access
Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight
Solange Sarkis, Chloé Chamard, Bianca Johansen, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Risk Assessment of Glaucoma in the Kyrgyz Republic
O A Bolbachan, G K Omorova, K. N. Bolbachan
City Healthcare (2025) Vol. 6, Iss. 1, pp. 66-75
Closed Access
Advances in the application of gelatin-based materials in anterior segment diseases
Zhijian Zhang, Chuanfeng An, Chunxiao Yan, et al.
International Journal of Biological Macromolecules (2025), pp. 142695-142695
Closed Access
Tackling visual impairment: emerging avenues in ophthalmology
Fang Lin, Yuxing Su, Chenxi Zhao, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Age-related driving mechanisms of retinal diseases and neuroprotection by transcription factor EB-targeted therapy
Samuel Abokyi, Dennis Y. Tse
Neural Regeneration Research (2024) Vol. 20, Iss. 2, pp. 366-377
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top